Congenital heart disease

Arterial Switch for Transposition of the Great Arteries: Treatment Timing, Late Outcomes, and Risk Factors

JACC AdvPublished Retrospective cohort study

Authors' conclusion

Mortality and hospital resource utilization are low, while reintervention remains relatively frequent.

Study context

Population
Patients undergoing arterial switch operation (ASO) for transposition of the great arteries with intact ventricular septum, England and Wales, 2000–2017
Participants
1,772 patients
Outcome
Survival, reintervention and hospital resource utilization after ASO
Methodological detailsnational dataset, multivariable regression, matching
  • National dataset
  • Multivariable regression
  • Matching

Main finding

As reported in the abstract

Mortality at 10 years after ASO
3.2% (95% CI: 2.5%-4.2%)
Cardiac reintervention at 10 years after ASO
10.7% (95% CI: 9.1%-12.2%)
Median time in hospital during ASO spell
19 days (IQR: 14, 24)
Time in hospital over first year after ASO
7 days (IQR: 4-10 days)
Outpatient days beyond fifth year
1 outpatient day/year
Median ASO age
9.5 days (IQR: 6.5-14.5 days)

Observational data: associations, not effects.

Further findings

Risk factors for late mortality and reintervention (subgroup with complete risk factor data)

ASO age and balloon atrial septostomy (BAS) use not associated with late mortality and reintervention
Cardiac or congenital comorbidities, low weight, and circulatory/renal support at ASO associated with late mortality and reintervention
  • Subgroup n = 652

BAS followed by ASO vs ASO as first procedure (within first 3 weeks of life)

Comparable early and late outcomes, including hospital resource utilization
  • Matched for patient characteristics

Original publication

Arterial Switch for Transposition of the Great Arteries: Treatment Timing, Late Outcomes, and Risk Factors. JACC Adv. Published 19 July 2023. doi:10.1016/j.jacadv.2023.100407

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.